Metraipolis › archive › dc_6fdb9be19460
Phase 1 LITESPARK-001 study of belzutifan in participants with advanced solid tumors: Results of the glioblastoma expansion cohort — Europe PMC PMID:42058763
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42058763
- DOI
- 10.1093/noajnl/vdaf242
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-08T10:04:27.320Z
- SHA-256 of the archived text
1a265aec16a9f1b69ab09a977e1479b14961675fef4075ffaaade22054df5188- Stable URL of this page
https://metraipolis.com/documento/dc_6fdb9be19460
How to cite
Phase 1 LITESPARK-001 study of belzutifan in participants with advanced solid tumors: Results of the glioblastoma expansion cohort — Europe PMC PMID:42058763 — Europe PMC (en), https://europepmc.org/article/MED/42058763 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_6fdb9be19460 (Metraipolis archive dc_6fdb9be19460, sha256 1a265aec16a9f1b69ab09a977e1479b14961675fef4075ffaaade22054df5188)
BibTeX
@misc{dc6fdb9be19460,
title = {Phase 1 LITESPARK-001 study of belzutifan in participants with advanced solid tumors: Results of the glioblastoma expansion cohort — Europe PMC PMID:42058763},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42058763},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_6fdb9be19460; sha256 1a265aec16a9f1b69ab09a977e1479b14961675fef4075ffaaade22054df5188},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42058763. Agents can read the archived copy with the MCP tool read_document.